Bafna Pharmaceuticals

80.03
+1.79
(2.29%)
Market Cap
189.30 Cr
EPS
-15.52
PE Ratio
-
Dividend Yield
0.00 %
Industry
Healthcare
52 Week High
96.00
52 Week Low
69.00
PB Ratio
3.62
Debt to Equity
0.70
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,687.60
#1 4,04,911.80
35.31
#1 49,887.20
12.06
#1 9,648
-18.99
51.79
6,658.00
1,76,749.00
80.67
8,184.00
0.89
1,600
23.05
57.57
1,502.40
1,21,350.00
23.59
28,409.50
7.12
5,291
30.28
51.21
3,341.40
1,13,088.20
58.70
10,785.70
11.59
1,656
10.91
65.60
1,301.00
1,08,577.70
19.20
28,905.40
12.36
5,578
21.14
51.26
981.80
98,792.10
21.15
19,831.50
13.82
3,831
-0.19
66.87
2,333.40
96,306.10
48.50
10,615.60
19.57
1,942
-10.91
42.68
1,935.20
88,379.70
26.95
20,141.50
#1 19.94
1,936
#1 112.49
42.45
34,940.00
74,245.10
52.60
6,097.20
10.80
1,201
27.83
77.32
1,121.00
65,107.90
#1 18.88
29,559.20
17.55
3,169
-0.50
44.15
Forecast
Actual
Growth Rate
Revenue Growth
-2.95 %
Net Income Growth
-90.21 %
Cash Flow Change
-1,816.76 %
ROE
-96.42 %
ROCE
-90.07 %
EBITDA Margin (Avg.)
-112.00 %

Quarterly Financial Results

Quarterly Financials
Jun 2018
Sept 2018
Jun 2019
Sept 2019
Revenue
12
9
7
12
Expenses
14
9
10
12
EBITDA
-2
0
-3
0
Operating Profit %
-15 %
2 %
-42 %
-3 %
Depreciation
1
1
1
1
Interest
1
1
0
0
Profit Before Tax
-4
-1
-4
-1
Tax
0
0
-2
0
Net Profit
-4
-1
-2
-1
EPS in ₹
0.00
-0.80
-0.90
-0.25

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
Total Assets
200
193
178
138
120
71
Fixed Assets
55
53
49
45
37
35
Current Assets
127
123
77
49
49
36
Capital Work in Progress
0
0
0
0
0
0
Investments
0
0
17
0
0
0
Other Assets
145
140
113
94
82
36
Total Liabilities
200
193
178
138
120
71
Current Liabilities
111
95
82
60
71
17
Non Current Liabilities
16
40
55
41
30
3
Total Equity
73
58
42
37
19
51
Reserve & Surplus
53
39
20
14
-5
-7
Share Capital
19
19
19
24
24
2

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
Net Cash Flow
0
-0
-0
0
-0
6
Investing Activities
60
-0
-5
38
15
33
Operating Activities
11
1
-1
-7
-2
-34
Financing Activities
-71
-1
6
-31
-14
7

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Promoter
91.74 %
90.39 %
90.40 %
90.42 %
90.42 %
90.12 %
90.00 %
90.02 %
90.00 %
90.00 %
88.74 %
88.43 %
88.30 %
88.30 %
88.30 %
88.30 %
75.00 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
8.53 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
6.31 %
6.23 %
6.26 %
6.10 %
5.24 %
5.50 %
5.62 %
5.61 %
5.64 %
5.64 %
6.87 %
7.66 %
7.48 %
7.37 %
7.69 %
7.66 %
11.06 %
Others
1.95 %
3.37 %
3.34 %
3.49 %
4.33 %
4.38 %
4.38 %
4.37 %
4.37 %
4.36 %
4.39 %
3.91 %
4.23 %
4.34 %
4.01 %
4.04 %
5.40 %
No of Share Holders
8,603
8,330
8,068
7,910
7,326
7,223
7,275
7,199
7,120
6,992
7,354
7,367
7,539
7,391
7,295
7,214
7,142

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %

No dividends have been distributed by the company in the past 10 years

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
26 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
26 May 2025 76.88 73.00
06 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
06 Feb 2025 77.43 78.02
11 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
11 Nov 2024 80.13 81.90
25 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
25 Sept 2024 82.30 80.11

Announcements

Closure of Trading Window3 days ago
Announcement Under Regulation 30 Of SEBI (LODR) Regulations 2015 - Re-Constitution Of Committees5 days ago
Announcement under Regulation 30 (LODR)-Change in Directorate5 days ago
Announcement under Regulation 30 (LODR)-Retirement5 days ago
Announcement under Regulation 30 (LODR)-Change in Management6 days ago
Announcement under Regulation 30 (LODR)-Change in Directorate6 days ago
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 30, 2025
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 29, 2025
Audited Financial Results For The Quarter & Year Ended March 31 2025May 26, 2025
Board Meeting Outcome for Outcome For The Board Meeting Held On 26/05/2025May 26, 2025
Announcement Under Regulation 30 Of SEBI (LODR) Regulations 2015 - Re-Constitution Of Nomination & Remuneration Committee.May 20, 2025
Board Meeting Intimation for Board Meeting Scheduled On May 26 2025May 19, 2025
Announcement Under Reg 30 Of SEBI (LODR) Regulations 2015 - AwardApr 29, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 08, 2025
Announcement under Regulation 30 (LODR)-Change in DirectorateApr 01, 2025
Announcement under Regulation 30 (LODR)-Resignation of DirectorApr 01, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Apr 01, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Apr 01, 2025
Disclosure Under Regulation 7(2) Of SEBI (PIT) Regulations 2015Mar 31, 2025
Notice of Offer for Sale of Shares by Promoter & Flooor PriceMar 26, 2025
Closure of Trading WindowMar 26, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 11, 2025
Integrated Filing (Financial)Feb 06, 2025
Unaudited Financial Results For The Quarter And Nine Months Ended 31/12/2024Feb 06, 2025
Board Meeting Outcome for Board Meeting Held On 06/02/2025Feb 06, 2025
Board Meeting Intimation for Board Meeting Scheduled On February 06 2025Jan 28, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 09, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 16, 2024
Unaudited Financial Results For The Quarter Ended 30.09.2024Nov 11, 2024
Board Meeting Outcome for Outcome Of Board Meeting Held On 11/11/2024Nov 11, 2024
Update on board meetingNov 04, 2024
Board Meeting Intimation for Board Meeting Scheduled On November 11, 2024Nov 04, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Oct 10, 2024
Closure of Trading WindowSep 28, 2024
Shareholder Meeting / Postal Ballot-Scrutinizer''s ReportSep 26, 2024
Announcement under Regulation 30 (LODR)-Change in DirectorateSep 25, 2024
Shareholder Meeting / Postal Ballot-Outcome of AGMSep 25, 2024
Announcement Under Reg 30 Of SEBI (LODR) Regulations, 2015 - AwardSep 09, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 03, 2024
Notice Of 29Th Annual General Meeting Of The Company For The F.Y 2023-2024Sep 02, 2024
Reg. 34 (1) Annual Report.Sep 02, 2024
Book Closure For 29Th Annual General Meeting (AGM)Aug 30, 2024
Shareholder Meeting - 29Th AGM On September 25, 2024Aug 30, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 16, 2024
Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015Aug 13, 2024
Board Meeting Outcome for Outcome Of The Board Meeting Held On 13/08/2024Aug 13, 2024
Unaudited Financial Results For The Quarter Ended 30.06.2024Aug 13, 2024
Board Meeting Intimation for Consideration And Approval Of The Unaudited Financial Results For The First Quarter Ended June 30, 2024.Aug 06, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Jul 11, 2024
Disclosure Under Regulation 30 Of SEBI (LODR) Regulations For Temporary Disruption Of Operations.Jun 29, 2024

Technical Indicators

RSI(14)
Neutral
63.49
ATR(14)
Volatile
3.17
STOCH(9,6)
Neutral
65.07
STOCH RSI(14)
Overbought
100.00
MACD(12,26)
Bullish
0.55
ADX(14)
Weak Trend
19.84
UO(9)
Bearish
57.68
ROC(12)
Uptrend And Accelerating
7.58
WillR(14)
Overbought
-7.18